Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05083273
Other study ID # CHRD1321
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 18, 2021
Est. completion date June 24, 2021

Study information

Verified date June 2021
Source Centre Hospitalier René Dubos
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to Assess the impact of HIV on the life course of patients aged 60 and over.


Description:

COREVIH IDF Nord and CERMES3 conducted a first qualitative survey of 32 HIV patients aged 60 and over. The study, in the form of an individual interview, aimed to identify the difficulties that PLWHIV may encounter in their life course, to question their future and the impact that HIV could have. From this study, a questionnaire was drawn up covering the points raised by the qualitative study. The questionnaire was designed by doctors of the four hospitals that participated in the first study and a sociologist from CERMES3. After patient's oral agreement obtained, the study questionnaire "Sociological study PVHIV ≥ 60 years" will be given to the patient for completion.


Recruitment information / eligibility

Status Completed
Enrollment 225
Est. completion date June 24, 2021
Est. primary completion date June 24, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria : People aged 60 and over living with HIV and view in consultation Patient participation agreement obtained Exclusion criteria : People living with HIV less than 60 years old

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cohorte
Completion of a socio-demographic, professional, medical and personal questionnaire

Locations

Country Name City State
France Hospital Beaujon, Clichy / Médecine Interne Clichy
France Hôpital Bichat Claude-Bernard - Service de Maladies Infectieuses et Tropicales Paris
France Hôpital Bichat Claude-Bernard -COREVIH Ile de France Nord Paris
France Université Paris Descartes - CERMES3 Paris
France Centre Hospitalier René Dubos Pontoise
France Hospital Delafontaine, Saint-Denis / Maladie infectieuse Saint-Denis

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier René Dubos

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determine the impact of HIV in the life cours of people aged 60 and over and the questioning of the future. People aged 60 and over will answer to a sociological questionnaire to identify the impact of HIV in their life cours and the questioning of the future, directly or indirectly linked to HIV. Through study completion, an average of 6 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04575545 - Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP
Completed NCT03195452 - QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient Phase 2
Active, not recruiting NCT04581746 - Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2) N/A
Not yet recruiting NCT05322083 - HIV A6 Genome In ART Unsuccessful Patients On DOR
Completed NCT04772469 - Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men N/A
Terminated NCT02898896 - Coronary Artery Disease (CAD) in Suppressed HIV-infected N/A
Completed NCT03671291 - Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV N/A